Croda International (LON:CRDA) Shares Cross Above 200 Day Moving Average – What’s Next?

Croda International Plc (LON:CRDA)’s share price passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 2,713.47 and traded as high as GBX 2,778. Croda International shares last traded at GBX 2,756, with a volume of 76,859,617 shares.

Wall Street Analysts Forecast Growth

CRDA has been the subject of a number of research analyst reports. Jefferies Financial Group cut Croda International to a “hold” rating and cut their price target for the company from GBX 3,100 to GBX 3,000 in a report on Tuesday, November 11th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Croda International from GBX 3,000 to GBX 3,100 and gave the company a “hold” rating in a research report on Thursday, October 16th. Citigroup reduced their target price on shares of Croda International from GBX 3,300 to GBX 3,050 and set a “neutral” rating on the stock in a research report on Friday, October 3rd. Finally, Berenberg Bank raised their price target on shares of Croda International from GBX 3,100 to GBX 3,300 and gave the company a “buy” rating in a report on Thursday, October 16th. Two analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Croda International has a consensus rating of “Hold” and an average price target of GBX 3,112.50.

Croda International Price Performance

The company has a 50 day moving average of GBX 2,733.98 and a 200 day moving average of GBX 2,713.47. The company has a current ratio of 2.72, a quick ratio of 2.25 and a debt-to-equity ratio of 30.90. The firm has a market cap of £3.85 billion, a price-to-earnings ratio of 17.90, a P/E/G ratio of 1.40 and a beta of 0.74.

Croda International Company Profile

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.